# Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE

> **NCT01827059** · PHASE2 · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 12 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension
- Congenital Heart Disease

## Interventions

- **DRUG:** Bosentan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01827059
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2018-02
- **Final completion:** 2018-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01827059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01827059, "Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01827059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*